SCHOTT Pharma AG & Co. KGaA, DE000A3ENQ51

SCHOTT Pharma AG & Co. KGaA / DE000A3ENQ51

04.03.2024 - 16:03:11

SCHOTT Pharma AG & Co. KGaA: Dr. Jens Schulte, sell


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

04.03.2024 / 16:02 CET/CEST
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title: Dr.
First name: Jens
Last name(s): Schulte

2. Reason for the notification

a) Position / status
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
SCHOTT Pharma AG & Co. KGaA

b) LEI
529900TU48UE99NHEY88 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE000A3ENQ51

b) Nature of the transaction
Disposal

c) Price(s) and volume(s)
Price(s) Volume(s)
40.0000 EUR 80000.00 EUR

d) Aggregated information
Price Aggregated volume
40.0000 EUR 80000.0000 EUR

e) Date of the transaction
01/03/2024; UTC+1

f) Place of the transaction
Name: Xetra
MIC: XETR



04.03.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language: English
Company: SCHOTT Pharma AG & Co. KGaA
Hattenbergstraße 10
55122 Mainz
Germany

 
End of News EQS News Service

89963  04.03.2024 CET/CEST fncls.ssp?fn=show_t_gif&application_id=1850787&application_name=news&site_id=trading_house_net~~~7efceac5-959a-43d6-afef-21ad42b6a5d4
@ dgap.de